Page 3 - Valbiotis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valbiotis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valbiotis Today - Breaking & Trending Today

Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap

A cash position of more than €20 million at the end of 2022, which provides the Company financial visibility until the end of the first half of 2024; A decisive year on the clinical front ....

Poitou Charentes , France General , Dennis Riedl , Seitosei Actifin , European Regional Development Fund , Laval University In Quebec City , Health Science , Research Development , French National Research Agency , Public Affairs , University Of Clermont Auvergne , Research Tax Credit , European Union , Innovative Company , Institute On Nutrition , United Nations Global Compact , Laval University , Quebec City , Functional Foods , First Patient Visit , American Association , Liver Diseases , Clermont Auvergne , Corporate Social Responsibility , Chief Financial , Statutory Auditor ,

Valbiotis Announces the Last Visit of the Last Patient in the Phase II/III REVERSE-IT Study on TOTUM•63, in Partnership with Nestlé Health Science

The last patient included in the study has completed the final protocol follow-up visit. The first results of the study will be released before the end of the first half of 2023, after the ....

United States , France General , South Africa , United Arab Emirates , New Zealand , Saudi Arabia , South Korea , Dennis Riedl , Seitosei Actifin , European Regional Development Fund , Health Science , Research Development , Health Nutrition , Industrial Affairs , Public Affairs , European Union , Valbiotis Executive Committee , Innovative Company , Chief Scientific , Chief Medical Officer , Good Clinical Practices , United Arab , North American , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator ,

Valbiotis Publishes Its Letter to Shareholders and Its 2023 Financial Calendar

Regulatory News: Valbiotis (FR0013254851 ALVAL, PEA SME eligible), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic ....

Dennis Riedl , Seitosei Actifin , Marc Delaunay , Carole Rocher , European Regional Development Fund , Young Innovative Company , Public Affairs , European Union , Research Development , Innovative Company , Regulatory News , Annual General Meeting , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator , Public Affairs Director ,

Valbiotis Announces Positive Results in the Bioavailability and Mode of Action TOTUM•854 Clinical Study, Against High Blood Pressure

TOTUM•854 protects human cells of the vascular wall, particularly against inflammation and oxidative stress, which is key to preventing worsening of high blood pressure. TOTUM•854 also reduces ....

United States , France General , Seitosei Actifin , European Regional Development Fund , American Heart Association , European Society Of Hypertension , Research Development , Young Innovative Company , Public Affairs , European Union , European Society Of Cardiology , Clinical Investigation Center At Clermont Ferrand University Hospital , Translational Research , Innovative Company , Executive Committee , European Society , Clinical Investigation Center , Clermont Ferrand University Hospital , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator , Public Affairs Director , Profi Marcel Torney ,

Valbiotis Announces Its Roadmap for 2023: a Pivotal Year in the Execution of Its Clinical, Industrial and Commercial Strategy

A decisive year in clinical terms with results expected in the first half of 2023 from the international Phase II/III REVERSE-IT study on TOTUM•63, a plant-based active substance that has already ....

European Regional Development Fund , Health Science , Research Development , Young Innovative Company , Valbioti Business Development Department , Public Affairs , European Union , Innovative Company , Valbioti Business Development , Valbiotis Board , Quebec City , Valbiotis Universal Registration Document , French Financial Markets Regulator ,